Folgen
OURANIA TROHATOU
OURANIA TROHATOU
National and Kapodistrian University of Athens
Bestätigte E-Mail-Adresse bei bio.demokritos.gr
Titel
Zitiert von
Zitiert von
Jahr
Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure
DS Zagoura, MG Roubelakis, V Bitsika, O Trohatou, KI Pappa, ...
Gut 61 (6), 894-906, 2012
2132012
Amniotic fluid and amniotic membrane stem cells: marker discovery
MG Roubelakis, O Trohatou, NP Anagnou
Stem cells international 2012, 2012
1582012
Platelet-rich plasma (PRP) promotes fetal mesenchymal stem/stromal cell migration and wound healing process
MG Roubelakis, O Trohatou, A Roubelakis, E Mili, I Kalaitzopoulos, ...
Stem Cell Reviews and Reports 10, 417-428, 2014
1402014
Mesenchymal stem/stromal cells in regenerative medicine: past, present, and future
O Trohatou, MG Roubelakis
Cellular reprogramming 19 (4), 217-224, 2017
1322017
In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells
MG Roubelakis, V Bitsika, D Zagoura, O Trohatou, KI Pappa, ...
Journal of cellular and molecular medicine 15 (9), 1896-1913, 2011
1132011
Sox2 suppression by miR-21 governs human mesenchymal stem cell properties
O Trohatou, D Zagoura, V Bitsika, KI Pappa, A Antsaklis, NP Anagnou, ...
Stem cells translational medicine 3 (1), 54-68, 2014
1012014
Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer
V Bitsika, MG Roubelakis, D Zagoura, O Trohatou, M Makridakis, ...
Stem cells and development 21 (7), 1097-1111, 2012
672012
GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders
P Fouka, H Alexopoulos, S Akrivou, O Trohatou, PK Politis, MC Dalakas
Journal of neuroimmunology 281, 73-77, 2015
562015
Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway
O Trohatou, EF Tsilibary, A Charonis, C Iatrou, G Drossopoulou
Journal of cellular and molecular medicine 21 (10), 2599-2609, 2017
432017
Human amniotic fluid stem cells as an attractive tool for clinical applications
O Trohatou, N P Anagnou, M G Roubelakis
Current Stem Cell Research & Therapy 8 (2), 125-132, 2013
432013
Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration
D Zagoura, O Trohatou, M Makridakis, A Kollia, N Kokla, M Mokou, ...
EBioMedicine 45, 542-552, 2019
342019
AF-MSCs fate can be regulated by culture conditions
DS Zagoura, O Trohatou, V Bitsika, M Makridakis, KI Pappa, A Vlahou, ...
Cell Death & Disease 4 (4), e571-e571, 2013
292013
miR-26a mediates adipogenesis of amniotic fluid mesenchymal stem/stromal cells via PTEN, Cyclin E1, and CDK6
O Trohatou, D Zagoura, NK Orfanos, KI Pappa, E Marinos, NP Anagnou, ...
Stem cells and development 26 (7), 482-494, 2017
252017
P0-Related Protein Accelerates Human Mesenchymal Stromal Cell Migration by Modulating VLA-5 Interactions with Fibronectin
MG Roubelakis, G Tsaknakis, FJ Lyu, O Trohatou, ACW Zannettino, ...
Cells 9 (5), 1100, 2020
52020
MFGE-8 identified in fetal mesenchymal-stromal-cell-derived exosomes ameliorates acute hepatic failure pathology
A Psaraki, D Zagoura, L Ntari, M Makridakis, C Nikokiraki, O Trohatou, ...
Iscience 26 (11), 108100, 2023
12023
Identification and Functional Analysis of Novel miRNA Target Genes That Control Mesenchymal Stem Cell Function
M Roubelakis, D Zagoura, O Trohatou, P Zotos, V Bitsika, S Kossida, ...
Blood 112 (11), 2424, 2008
12008
Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure
KI Pappa, A Kapelouzou, A Antsaklis, NP Anagnou, DS Zagoura, ...
BMJ, 2011
2011
NOVEL HUMAN AMNIOTIC FLUID (AF) MESENCHYMAL STEM CELL (MSC) THERAPEUTIC APPROACHES FOR TARGETING BLADDER CANCER
V Bitsika, NP Anagnou, MG Roubelakis, D Zagoura, KI Pappa, O Trohatou, ...
EXPERIMENTAL HEMATOLOGY 37 (9), S87-S87, 2009
2009
DIFFERENTIATION PROPERTIES OF HUMAN AMNIOTIC FLUID MESENCHYMAL STEM CELLS (AF-MSC): IN VITRO AND IN VIVO APPLICATIONS
D Zagoura, NP Anagnou, MG Roubelakis, V Bitsika, KI Pappa, O Trohatou, ...
EXPERIMENTAL HEMATOLOGY 37 (9), S51-S52, 2009
2009
Development of Novel Amniotic Fluid Mesenchymal Stem Cell Therapeutic Approaches for Targeting Bladder Cancer
B Vasiliki, MG Roubelakis, D Zagoura, O Trohatou, KI Pappa, A Vlahou, ...
MOLECULAR THERAPY 17, S230-S230, 2009
2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20